Related Experiment Video
Updated: Jun 28, 2026
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Classifying antipsychotic agents : need for new terminology.
Ripu D Jindal1, Matcheri S Keshavan
1Department of Psychiatry, University of Ottawa School of Medicine, Ottawa, Ontario, Canada. ripu.jindal@gmail.com
CNS Drugs
|November 13, 2008
Summary
This review proposes a new classification system for antipsychotic agents based on receptor binding affinity, moving beyond traditional first- and second-generation categories. Understanding these profiles predicts efficacy, tolerability, and adverse effects like weight gain.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Current classification of antipsychotic agents into first- and second-generation has limitations.
- Growing understanding of the pharmacological basis of antipsychotic efficacy and tolerability exists.
- Receptor binding affinity is a key determinant of antipsychotic action.
Purpose of the Study:
- To highlight the drawbacks of the current antipsychotic classification system.
- To propose a new classification system based on receptor binding affinity profiles.
- To explain the pharmacological basis of antipsychotic efficacy and adverse effects.
Main Methods:
- Review of converging data from multiple lines of research.
- Analysis of receptor binding affinity profiles of antipsychotic agents.
- Detailed explanation of the pharmacological basis for efficacy and adverse effects.
Main Results:
- Receptor binding affinity can predict antipsychotic efficacy and tolerability.
- Traditional classification does not fully capture the pharmacological nuances of agents.
- Pharmacological profiles explain antipsychotic-induced weight gain, diabetes mellitus, and cognitive effects.
Conclusions:
- A new classification system for antipsychotic agents based on receptor binding affinity is warranted.
- This approach offers a more predictive and nuanced understanding of antipsychotic action.
- Understanding receptor binding profiles is crucial for optimizing treatment and minimizing adverse effects.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...